Stocks
Intuitive Surgical Financial Statements (ISRG) |
||||||||||
| Intuitive Surgicalsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 07.02.2020 | 10.02.2021 | 03.02.2022 | 10.02.2023 | 31.01.2024 | 18.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 4 479 | 4 358 | 5 710 | 6 222 | 7 124 | 7 867 | |||
| Operating Income, bln rub | 1 375 | 773.6 | 1 821 | 1 211 | 1 767 | 2 064 | ||||
| EBITDA, bln rub | ? | 1 375 | 1 050 | 1 821 | 1 577 | 2 394 | 2 505 | |||
| Net profit, bln rub | ? | 1 379 | 1 061 | 1 705 | 1 322 | 1 798 | 2 243 | |||
| OCF, bln rub | ? | 1 598 | 1 485 | 2 089 | 1 491 | 1 814 | 1 594 | |||
| CAPEX, bln rub | ? | 425.6 | 341.5 | 353.5 | 532.4 | 1 064 | 1 235 | |||
| FCF, bln rub | ? | 1 173 | 1 143 | 1 736 | 958.4 | 749.6 | 359.4 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 8.00 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.36% | ||||
| OPEX, bln rub | 1 736 | 1 811 | 2 138 | 2 619 | 2 963 | 3 205 | ||||
| Cost of production, bln rub | 1 368 | 1 497 | 1 752 | 2 026 | 2 395 | 2 598 | ||||
| R&D, bln rub | 557.3 | 595.1 | 671.0 | 879.0 | 998.8 | 1 111 | ||||
| Interest expenses, bln rub | 0.000 | 0.000 | 0.000 | 29.7 | 0.000 | 28.7 | ||||
| Assets, bln rub | 9 733 | 11 169 | 13 555 | 12 974 | 15 442 | 17 743 | ||||
| Net Assets, bln rub | ? | 8 285 | 9 759 | 11 952 | 11 113 | 13 308 | 15 583 | |||
| Debt, bln rub | 76.4 | 79.9 | 87.0 | 93.8 | 89.8 | 0.000 | ||||
| Cash, bln rub | 5 845 | 6 869 | 8 620 | 6 742 | 5 223 | 4 232 | ||||
| Net debt, bln rub | -5 769 | -6 789 | -8 533 | -6 648 | -5 133 | -4 232 | ||||
| Ordinary share price, rub | 197.1 | 272.7 | 359.3 | 265.4 | 337.4 | 278.5 | ||||
| Number of ordinary shares, mln | 346.2 | 351.0 | 356.1 | 355.7 | 351.2 | 355.8 | ||||
| Market cap, bln rub | 68 219 | 95 718 | 127 947 | 94 385 | 118 481 | 99 076 | ||||
| EV, bln rub | ? | 62 450 | 88 929 | 119 414 | 87 737 | 113 347 | 94 844 | |||
| Book value, bln rub | 7 865 | 9 345 | 11 537 | 10 714 | 12 920 | 15 210 | ||||
| EPS, rub | ? | 3.98 | 3.02 | 4.79 | 3.72 | 5.12 | 6.30 | |||
| FCF/share, rub | 3.39 | 3.26 | 4.87 | 2.69 | 2.13 | 1.01 | ||||
| BV/share, rub | 22.7 | 26.6 | 32.4 | 30.1 | 36.8 | 42.7 | ||||
| EBITDA margin, % | ? | 30.7% | 24.1% | 31.9% | 25.3% | 33.6% | 31.8% | |||
| Net margin, % | ? | 30.8% | 24.3% | 29.9% | 21.3% | 25.2% | 28.5% | |||
| FCF yield, % | ? | 1.72% | 1.19% | 1.36% | 1.02% | 0.63% | 0.36% | |||
| ROE, % | ? | 16.6% | 10.9% | 14.3% | 11.9% | 13.5% | 14.4% | |||
| ROA, % | ? | 14.2% | 9.50% | 12.6% | 10.2% | 11.6% | 12.6% | |||
| P/E | ? | 49.5 | 90.2 | 75.1 | 71.4 | 65.9 | 44.2 | |||
| P/FCF | 58.2 | 83.7 | 73.7 | 98.5 | 158.1 | 275.7 | ||||
| P/S | ? | 15.2 | 22.0 | 22.4 | 15.2 | 16.6 | 12.6 | |||
| P/BV | ? | 8.67 | 10.2 | 11.1 | 8.81 | 9.17 | 6.51 | |||
| EV/EBITDA | ? | 45.4 | 84.7 | 65.6 | 55.6 | 47.3 | 37.9 | |||
| Debt/EBITDA | -4.20 | -6.47 | -4.69 | -4.22 | -2.14 | -1.69 | ||||
| R&D/CAPEX, % | 130.9% | 174.3% | 189.8% | 165.1% | 93.9% | 90.0% | ||||
| CAPEX/Revenue, % | 9.50% | 7.84% | 6.19% | 8.56% | 14.9% | 15.7% | ||||
| Intuitive Surgical shareholders | ||||||||||
